Literature DB >> 18475481

Leukotriene inhibition in hamster periodontitis. A histochemical and morphometric study.

B Baroukh1, J L Saffar.   

Abstract

The effects of leukotriene (LT) inhibition on gingival and adjacent bone compartments were assessed by using phenidone (100 mg/kg/d) and ketoconazole (50 mg/kg/d) given for 4 weeks to periodontitis-affected hamsters. In the gingiva the two agents significantly decreased PMNL recruitment and migration and increased the vascular lumen. At the bone level, they reduced significantly preosteoclast and osteoclast numbers but did not affect osteoclast activity. Phenidone had no action on periodontitis induced inhibition of bone formation; in contrast ketoconazole enhanced formation. As both phenidone and ketoconazole are unspecific LT inhibitors it cannot be ascertained that the effects observed were actually due to LT inhibition. However, phenidone and ketoconazole induced changes different from indomethacin used in previous studies to inhibit the cyclooxygenase pathway. These discrepancies suggest that LT inhibition occurred in the present study and that they participate in gingival inflammation and osteoclastic destruction during hamster periodontitis.

Entities:  

Year:  1992        PMID: 18475481      PMCID: PMC2365357          DOI: 10.1155/S0962935192000504

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  23 in total

Review 1.  Leukotriene receptor antagonists as potential therapeutic agents.

Authors:  D W Snyder; J H Fleisch
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

Review 2.  The acute inflammatory reaction.

Authors:  P A Ward; R M Marks
Journal:  Curr Opin Immunol       Date:  1989-10       Impact factor: 7.486

3.  Identification of osteoclasts and their mononuclear precursors. A comparative histological and histochemical study in hamster periodontitis.

Authors:  B Baroukh; J L Saffar
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

4.  Leukotriene B4 increases intracellular calcium concentration and phosphoinositide metabolism in mouse osteoblasts via cyclic adenosine 3',5'-monophosphate-independent pathways.

Authors:  J R Sandy; M C Meikle; B R Martin; R W Farndale
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

5.  1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets.

Authors:  G J Blackwell; R J Flower
Journal:  Prostaglandins       Date:  1978-09

6.  Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes.

Authors:  I Tatsuno; H Saito; K J Chang; Y Tamura; S Yoshida
Journal:  Agents Actions       Date:  1990-03

7.  Endothelial cells can synthesize leukotriene B4.

Authors:  K D Nolan; B A Keagy; F M Ramadan; G Johnson; D C Henke
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

8.  Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells.

Authors:  T A Reinhardt; R L Horst
Journal:  Arch Biochem Biophys       Date:  1989-08-01       Impact factor: 4.013

9.  Periodontal and femoral bone status in periodontitis-affected hamsters receiving a high dose indomethacin treatment.

Authors:  P Carter-Bartlett; J M Dersot; J L Saffar
Journal:  J Biol Buccale       Date:  1989-06

10.  Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.

Authors:  R Moser; B Schleiffenbaum; P Groscurth; J Fehr
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

View more
  1 in total

Review 1.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.